One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi

Cecilia Kanyama,Sile F. Molloy,Adrienne K. Chan,Duncan Lupiya,Chimwemwe Chawinga,Jack Adams,Philip Bright,David G. Lalloo,Robert S. Heyderman,Olivier Lortholary,Shabbar Jaffar,Angela Loyse,Joep J. van Oosterhout,Mina C. Hosseinipour,Thomas S. Harrison

CLINICAL INFECTIOUS DISEASES（2020）

引用 14|浏览34

暂无评分

摘要

In Malawi, 236 participants from the Advancing Cryptococcal Meningitis Treatment for Africa trial were followed for 12 months. The trial outcomes reported at 10 weeks were sustained to 1 year. One-week amphotericin B plus flucytosine was associated with the lowest 1 year mortality (27.5% [95% confidence interval, 16.3 to 44.1]).

查看译文

关键词

cryptococcal meningitis,treatment,long-term follow-up,Malawi,HIV

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要